Financials
- Market Capitalization 2.99 B
- Employee 67
- Founded 2016
- CEO N/A
- Website www.enliventherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG00CP3BDD4
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-8.42
Fiyat/satışlar oranı
-8 232.35
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 1642 | AMLX Amylyx Pharmaceuticals, Inc. - Common Stock | 27.48 USD | -2.35% | -1.75% | -13.69% | +95.59% | 3.06 B USD | ||
| 1651 | DNLI Denali Therapeutics Inc. - Common Stock | 18.95 USD | -2.57% | -4.92% | -10.15% | +17.19% | 3.03 B USD | ||
| 1667 | DYN Dyne Therapeutics, Inc. - Common Stock | 15.96 USD | -4.09% | +2.97% | -13.26% | -31.82% | 2.98 B USD | ||
| 1722 | ZLAB Zai Lab Limited - American Depositary Shares | 24.59 USD | -1.60% | -8.25% | +1.40% | -7.87% | 2.76 B USD |